Skip to the page

Data / Form D filings / PolyVascular, Inc.

PolyVascular, Inc.: Form D filing

PolyVascular, Inc., a health care company in Houston, TX, filed a Form D with the SEC in 2023. The latest, on July 18, 2023, reports $795,000 sold of a $2 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6501 Navigation Blvd, Suite 02, Houston, TX, 77011
Phone
(832) 323-1843
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1983819

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 18, 2023New notice$2,000,000$795,000$1,205,0005Jun 26, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul SwegleExecutive Officer
Daniel HarringtonDirector
Kwonsoo ChunDirector
Henri JustinoDirector
Tim SmokoffExecutive Officer, Director

Other health care companies in Texas that filed recently

Every Form D from the week of Jul 17, 2023 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what PolyVascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.